History A seven-year-old atopic boy has been treated for phlyctenulosis with mild topical steroids. However, he developed dramatic changes at the right limbus in two weeks. He also had past history of vernal keratoconjunctivitis (VKC) with poor compliance to treatment....
History A 31-year-old female patient presented with history of gradual downward displacement of the globe over the last six months. The superotemporal mass then became palpable (Figure 1). Lateral orbitotomy was performed following CT scans (Figure 2). Figure 1. Figure...
That time of year is coming around again and the ophthalmic community are ironing their ties and polishing their shoes ready for the Royal College of Ophthalmologists’ Annual #EyeConUK Congress 2025, taking place at the ACC, Liverpool, between 19–22 May....
The end of 2024 offered us many reasons to celebrate, one of which was the eventful, annual UKISCRS conference in London, during which we saw our editor, David Lockington, step into the role of President and lead the society into...
In the first article of a two-part series (see Part 2 here), the authors provide an overview of this hugely successful partnership and how they overcame the challenges of COVID-19. What began in 2008 as a connection between equals, has...
The new President of the BCLA has used his inaugural address to urge the sector to have “meaningful” conversations after eye exams and deliver “better vision outcomes” for patients.
This article offers some app and web service suggestions. A few are new and others well established, but all offer useful features. Messaging for teams Many businesses provide their employees with instant messaging services to allow calling, messaging and collaboration....
The programme includes session around the iStent inject W from Mr Imran Masood, Birmingham, Mr Salman Sadiq, Newcastle, Mr Karim El-Assal, Sunderland and Conor Lavery. Introductions and conclusions from Niven Smith, Glaukos.
A Multi-Specialty in-person meeting, delivering a world class scientific programme. Offering symposia, YO sessions, workshops, live surgery, debates, mystery cases and updates on all topics
This article discusses the use of topical and systemic therapy in the management of advanced periocular tumours. It focuses on those that have gained United States Food and Drug Administration approval; namely imiquimod, vismodegib, sonidegib, pembrolizumab and cemiplimab. Imiquimod is...
It is abundantly clear that the burden of diabetes is rapidly increasing, as there are now 415 million adults with diabetes in the world, with a projected rise to 642 million by 2040 [1]. This equates to 1 in 10...